Can the timing of perioperative fluids affect hospital length of stay?
In this issue of the Journal, Weinberg et al report the findings of a retrospective observational study on the effect of using a surgery-specific goal-directed therapy (GDT) algorithm on the incidence of complications and hospital length of stay following pancreaticoduodenectomy (PD) 1 . This was a worthwhile endeavour given the high incidence of complications and the typical extended hospital length of stay in this group of patients. Any therapeutic manoeuvre that would improve outcomes would be a welcome advance.
The authors had introduced an early recovery after surgery (ERAS) protocol for all their PD patients from January 2010. Since then, depending on anaesthetist preference, a surgeryspecific GDT algorithm based on stroke volume variation (SVV) and cardiac output was implemented in some patients, in addition to the ERAS protocol. Overall 47 patients had this GDT option, while the remaining 98 had usual ERAS care. When the authors retrospectively examined the outcomes, the differences between the two groups were impressive. The GDT group had an incidence of acute respiratory distress syndrome of 2%, postoperative pneumonia 4%, pulmonary atelectasis 2%, non-cardiogenic pulmonary oedema 2%, cardiogenic pulmonary oedema 0%, and myocardial infarction 0%, compared to 4%, 13%, 13%, 4%, 12%, and 1% for these complications in the usual ERAS care group. Moreover, patients receiving GDT had a median hospital length of stay of 10 days versus 13 days in the usual ERAS care group. This was despite a similar frequency of surgical (non-cardiorespiratory) complications between groups. These findings represent a major improvement in outcome. If the improvement can be attributed to the use of GDT, then GDT should be considered for all patients undergoing PD. The question is, however, are these findings due to GDT?
The main therapeutic difference between their GDT group versus their usual ERAS care group was a reduction in intraoperative fluid during surgery. The median (interquartile range, IQR) for fluid in the GDT group was 3,000 ml (2,050-4,175 ml) versus 4,500 ml (3,275-5,325 ml) in the usual ERAS care group. This resulted in a positive fluid balance of 2,200 ml (1,005-3,300 ml) in the GDT group at the end of surgery versus 3,632 ml (2,380-4,685 ml) in the usual ERAS care group. This difference was not affected significantly when adjusted for covariates such as epidural anaesthesia. This extra ~200 ml per hour over a median of about 7 to 8 hours of surgery could potentially result in relative fluid overload, promoting the higher incidence of acute cardiorespiratory distress, pneumonia, atelectasis, and pulmonary oedema.
This would be a plausible mechanism by which GDT influenced these complications. However, in the ensuing 16 hours or so postoperatively, the GDT group received relatively more intravenous fluid than the usual ERAS care group, such that by day one the fluid balances were similar: +1,198 ml (700-1,729 ml) in the GDT group vs +977 ml (419-2,044 ml) in the usual ERAS care group. If anything, the fluid balance was more positive in the GDT group. Therefore, if the extra fluid were causing these complications, a more complex hypothesis of how the complications occurred would be required, implicating specifically intraoperative versus early postoperative fluids.
If we accept that the additional intraoperative fluid caused the increased incidence of cardiorespiratory complications, we might still have difficulty explaining the mechanism for the difference in hospital length of stay. How could additional fluid intraoperatively, but with a comparable fluid balance by day one, cause patients 12 days later to stay an average of a further six days (mean hospital length of stay in the GDT group was 12 days versus 18 days in the usual ERAS care group)? Were the cardiorespiratory complications so severe that they persisted up to 18 days or more postoperatively? Alternatively did they occur later during the hospital stay, in which case it would be more difficult to attribute them to intraoperative fluids? Moreover, the extra six days was the average across all patients in the usual ERAS care group, not only those who developed cardiorespiratory complications. The total number of patients who developed cardiorespiratory complications is not stated. However, if no more than one cardiorespiratory complication occurred per patient (which would be unlikely), then a total of 47 patients would have had a cardiorespiratory complication, leaving at least 51 patients without a cardiorespiratory complication. To obtain an average increased length of stay of six days across all 98 patients, those developing cardiorespiratory complications would need to have had an average of >12 days extra in hospital. In other words, the extra fluid intraoperatively versus postoperatively would have been responsible for more than doubling the average length of stay in those patients who developed cardiorespiratory complications; from 12 days to over 24 days! Is there an alternative explanation for the cause of the increased length of stay?
The authors themselves provide strong clues that would suggest or at least be consistent with an alternative explanation. In a recent study of 150 patients having the same procedure (PD) in the same institution, the authors reported that a high surgical caseload (versus low surgical caseload) was 'strongly associated with an earlier hospital discharge' 2 . In fact the odds ratio was 9.8; 95% confidence interval 3.3-33.8, P <0.001. More compelling still was the fact that 85 patients from this previous study were included in the surgery-specific GDT study 2 . Unfortunately, the authors did not repeat the analysis of the influence of surgical caseload on length of stay for the GDT study, stating that after including the additional 60 patients such analysis would not be meaningful. Nevertheless, the findings of their previous study (which included 85 of the same patients) remain; surgical caseload at their institution has, or has had over much of the period of their study, a large effect on hospital length of stay, independent of fluid intervention or GDT.
The other potential explanation, which the authors' own data also support, is a trend to reduced hospital length of stay over time. For example, in their previous study of 150 patients between 2006 and 2012 (of which 85 were included in the GDT study) the median length of stay for patients undergoing uncomplicated PD was 14 days 2 . This was four days longer than the GDT group of their GDT study and one day longer than the usual ERAS care group of their GDT study, despite the inclusion of patients with complications in the GDT study. Clearly the authors have witnessed a substantial reduction in length of stay for PD in their institution between 2006-2012 and 2010-2015. Therefore, if there were more patients receiving GDT toward the later stages of the study than the earlier stages, the observed shorter length of stay in the GDT group could be explained by this trend alone, without having to consider other potential causes such as fluid intervention or a surgery-specific GDT algorithm. Unfortunately, the authors were not able to provide data on the relative proportions of GDT versus usual ERAS care over time.
This issue of the effect of liberal versus restricted fluid strategies for a range of different types of surgery remains controversial despite many studies, reviews, and meta-analyses suggesting a benefit of a more restrictive approach [3] [4] [5] . The same applies to GDT [6] [7] [8] [9] , the assessment of which is further complicated by questions related to the accuracy of monitoring strategies (e.g. mode of predicting fluid responsiveness or estimating cardiac output), the equivalence of monitoring strategies across studies 10, 11 , and the choice, design, and compliance with any particular GDT algorithm. The relationship between fluid intervention and GDT is also unclear, because GDT may result in either increased or decreased perioperative fluid administration 12, 13 .
The first large-scale multicentre randomised controlled trial on restricted versus liberal fluid therapy in major abdominal surgery (the RELIEF study) has been completed 14 . It is anticipated that the findings of this study will be reported in early 2018. It is of interest that this study randomised fluid management, but not necessarily monitoring approaches or GDT strategies.
Weinberg et al are very open about the limitations of their study. They point out that their study was retrospective and observational, with the choice of anaesthetic technique and whether or not to use GDT being at the discretion of individual anaesthetists, albeit within an ERAS framework. On the other hand, they used a robust method for identifying and classifying complications. They also point out that their findings pertain only to PD, and their own surgeryspecific GDT algorithm, which used a Flotrac® (System 4, Edwards Life Sciences, Irvine, CA, USA)-derived SVV >20% to guide fluid therapy and cardiac index to guide vasoactive drug administration. They acknowledge that their GDT group received more noradrenaline and dopamine than the usual ERAS care group, which could be a confounding factor. They also clearly explain that they cannot exclude an influence of differences in surgeon caseload on the incidence of complications, and that increases in skill base of both anaesthetists and surgeons could have impacted on improvements in length of stay. More importantly still, they emphasise that the larger intraoperative fluid volume in their usual ERAS care group may have been in response to surgical factors; these factors could have caused the increased length of stay. They also cautioned that they could not identify the specific reasons (cardiorespiratory versus surgical) for longer lengths of stay in the usual ERAS care group.
Weinberg et al are to be commended for their study, and their impressive results, irrespective of the cause of the improvements reported. Their results cannot be ignored, although each institution should consider whether the Weinberg et al usual ERAS care fluid administration volumes, the duration of surgery (median 7-8 hours), the complication rates (>64%), and hospital lengths of stay (median 12 days) would be typical of their own institution. Moreover, while it is possible that their use of a surgery-specific GDT algorithm resulted in substantial reductions in cardiorespiratory complications, the mechanism of how this could have occurred is unclear, given the similar fluid balances by day one. Similarly, while the use of the GDT algorithm may have resulted in a substantial reduction in hospital length of stay, there are several compelling alternative explanations for this finding that cannot be excluded. Weinberg at al have very sensibly called for further randomised prospective studies to confirm whether their observations are real and reproducible.
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